|
⚲
|
| Keyboard |
| Lamond David
✚
|
|
|---|---|
| CIK # | 0001770790 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001770790] | |
| 4 | [0001770790] | |
| SC 13D | [0001770790] | |
| SC 13G | [0001770790] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Lamond David | Quince Therapeutics Inc | [2024-11-13] |
| Lamond David | Cortexyme Inc | [2019-09-30] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Quince Therapeutics Inc | |
| Lamond David | |
| Lucira Health Inc | |
| Applied Molecular Transport Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Quince Therapeutics Inc QNCX
Director Stock Option (Right to Buy) · derivative
|
2026-01-02 | Grant | 29,423 | $0.00 | |
|
Quince Therapeutics Inc QNCX
Director Stock Option (Right to Buy) · derivative
|
2025-06-04 | Grant | 27,000 | $0.00 | |
|
Quince Therapeutics Inc QNCX
Director Stock Option (right to buy) · derivative
|
2025-01-02 | Grant | 47,587 | $0.00 | |
|
Quince Therapeutics Inc QNCX
Employee Stock Option (right to buy) · derivative
|
2024-06-05 | Grant | 27,000 | $0.00 | |
|
Quince Therapeutics Inc QNCX
Common Stock
|
2023-12-14 | Buy | 22,627 | $1.04 | 23,532 |
|
Quince Therapeutics Inc QNCX
Common Stock
|
2023-12-13 | Buy | 22,627 | $1.00 | 22,627 |
|
Quince Therapeutics Inc QNCX
Common Stock
|
2023-12-12 | Buy | 300 | $1.00 | 300 |
|
Quince Therapeutics Inc QNCX
Common Stock
|
2023-12-12 | Buy | 22,327 | $1.02 | 22,774 |
|
Quince Therapeutics Inc QNCX
Common Stock
|
2023-12-07 | Buy | 19,123 | $1.01 | 19,314 |
|
Quince Therapeutics Inc QNCX
Common Stock
|
2023-12-06 | Buy | 19,123 | $1.02 | 19,505 |
|
Quince Therapeutics Inc QNCX
Common Stock
|
2023-12-05 | Buy | 19,123 | $1.01 | 19,314 |
|
Quince Therapeutics Inc QNCX
Common Stock
|
2023-12-01 | Buy | 14,378 | $0.94 | 13,515 |
|
Quince Therapeutics Inc QNCX
Common Stock
|
2023-11-30 | Buy | 14,378 | $0.90 | 12,940 |
|
Quince Therapeutics Inc QNCX
Common Stock
|
2023-11-29 | Buy | 14,378 | $0.98 | 14,090 |
|
Quince Therapeutics Inc QNCX
Common Stock
|
2023-08-31 | Buy | 41,026 | $1.32 | 54,154 |
|
Quince Therapeutics Inc QNCX
Common Stock
|
2023-08-30 | Buy | 41,026 | $1.31 | 53,744 |
|
Quince Therapeutics Inc QNCX
Common Stock
|
2023-08-17 | Buy | 24,766 | $1.29 | 31,948 |
|
Quince Therapeutics Inc QNCX
Common Stock
|
2023-08-16 | Buy | 117,348 | $1.29 | 151,379 |
|
Quince Therapeutics Inc QNCX
Common Stock
|
2023-08-15 | Buy | 107,886 | $1.32 | 142,410 |
|
Quince Therapeutics Inc QNCX
Stock Option (right to buy) · derivative
|
2023-05-24 | Grant | 27,000 | $0.00 | |
| showing 20 of 63 most recent transactions | |||||